Bismacine may cause serious adverse events


The FDA ( Food and Drug Administration ) warns consumers and healthcare professionals not to use a product called Bismacine, also known as Chromacine.
The FDA is investigating one report of a death and several reports of injury related to the administration of Bismacine.

Bismacine is an injectable product that has been used to treat Lyme disease. But Bismacine is not approved for anything, including Lyme disease.

Bismacine is not a pharmaceutical and is mixed individually by druggists. It is prescribed or administered by doctors of alternative health or by people claiming to be medical doctors.

This product contains high amounts of bismuth, a heavy metal that is used in some medications taken by mouth to treat Helicobacter pylori, but that is not approved in any form for use by injection.

One person died as a result of treatment with Bismacine, and another person was hospitalized after receiving a Bismacine treatment. Other individuals who have used or been administered this product have also suffered serious adverse events. Possible effects of bismuth poisoning include cardiovascular collapse and kidney failure.

Source: FDA, 2006


XagenaMedicine2006